Withdrawal first, relapse later: NU675's Unit 8 analysis splits a composite retiree's early dizziness from her later depression by onset, the kind of symptom and likeness to her 2019 episode. Searches like "nu 675 unit 8 assignment example", "nu675 unit 8 sample" and "nu675 unit 8 example" land here.
What a finished NU675 Unit 8 discontinuation case analysis looks like
A timeline figure and four pages of analysis. The timeline marks each taper step, bracketed, across [four] weeks, then plots two symptom clusters against days since the last step. Cluster one, dizziness, nausea, shock-like sensations with eye movement, irritability and vivid dreams, begins on day [2], scores [11] on the Discontinuation-Emergent Signs and Symptoms checklist (Rosenbaum et al., 1998) and fades by day [16]. Cluster two, early waking, loss of interest, guilt about money and a BDI-II of [24], begins around week [5] and is still building. Beneath the figure, a table sets each cluster against three tests: onset relative to the last reduction, whether the symptoms were ever part of her depression, and how closely they match her 2019 episode, whose record the analysis quotes. Its final section recommends a response to each.
How a NU675 Unit 8 example is structured
Timing organizes the analysis, because the two clusters are easiest to tell apart on a calendar. Each is examined against the same three tests: cluster one begins within days, consists largely of sensations she never had while depressed, and resembles nothing in her history; cluster two emerges weeks later, mirrors the early waking and guilt recorded in 2019, and is intensifying rather than fading. The paper does not overclaim. It notes that withdrawal can last longer than older guidance suggested, citing NICE's 2019 revision, and that a fast taper may have contributed to both clusters. Recommendations follow the verdicts: a slower, proportionate taper had withdrawal been the only problem; for the relapse, a return to treatment with a review of what dose and duration now make sense. Her own account of each cluster is quoted.
Two clusters on one calendar
Plotting symptoms against days since the last reduction shows two humps, not one. The first rises within days and falls within two weeks; the second begins weeks later and climbs. Seeing them on a single axis is what makes the separation persuasive.
Symptoms she never had before
Dizziness on turning her head, nausea and shocks with eye movement were absent from her 2019 episode. The analysis treats that absence as strong evidence of withdrawal, since symptoms foreign to the original illness rarely signal its return.
The episode she recognizes
Early waking, withdrawal from her grandchildren and guilt about finances appear in the record of her previous episode almost word for word. The analysis quotes that record beside her current account, and she herself says it feels like before.
Honest about the overlap
Irritability and poor sleep can belong to either cluster, and the analysis says so rather than assigning them by convenience. A concession follows, with the case for proportionate reductions cited: a slower taper might have produced a different course.
A response for each diagnosis
Withdrawal would call for reassurance, time and a slower schedule if the drug were resumed and reduced again; relapse calls for treatment. The analysis keeps the two responses separate, with every amount bracketed and the decision left to her prescriber and her.
Where marks go in NU675 Unit 8
Collapsing the two clusters into one is the error graders mark hardest here, in either direction. Calling everything relapse and restarting full treatment on day two misreads withdrawal; calling everything withdrawal at week six leaves a returning depression untreated. The analysis earns credit by applying explicit tests, and a paper that separates the clusters by instinct, without stating onset, symptom novelty and resemblance to past episodes, cannot show its work. Graders check that withdrawal is described accurately, including that it can outlast older textbook estimates, and that sources are dated. Symptoms that could fit either cluster should be flagged, not quietly assigned. A missing validated measure for either cluster, figures stated outside brackets, or recommendations that ignore her own preference each cost a few points.
Get a NU675 Unit 8 example written to your instructions
Put every date your NU675 Unit 8 case gives into what you send: each taper step, the day each symptom began and any record of past episodes, plus the rubric. Expect the first custom analysis back within 24-48h, free, testing each cluster against onset, novelty and resemblance, then pairing each with its response.
NU675 Unit 8 questions, answered
Can withdrawal and relapse happen in the same patient?
Yes, and a strong analysis allows for it. One set of symptoms can start soon after a dose step and fade, while a return of the original illness emerges later. Separate them by onset, by whether the symptoms were part of the illness before, and by resemblance to past episodes, and flag any symptom that could belong to either.
How long can antidepressant withdrawal last?
Typically days to a few weeks, but some people report symptoms for considerably longer, and guidance has shifted to acknowledge this. NICE revised its advice in 2019 after reviews suggested withdrawal was more common and longer-lasting than earlier guidance stated. Cite the source you rely on and avoid presenting a fixed duration as certain.
Should the analysis recommend restarting the antidepressant?
It can discuss restarting where the evidence points to relapse, with the reasoning shown and every amount bracketed. For withdrawal alone, the options include waiting, or resuming and then tapering more slowly. Present the choices with their rationale and treat the final call as one for the prescriber and patient together, since a coursework analysis is not a prescribing document for anyone.